Aurelio, Mario H.
HRN: 24-47-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/11/2024
02/17/2024
IVT
600mg
Q8
DM Foot Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes